Company profile for Vycellix

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Vycellix, Inc. is a private, immuno-centric discovery life science company, advancing the development of transformational platform technologies to enhance and optimize next-generation cell & gene-based therapies, including T cell and Natural Killer (NK) cell-based cancer therapies. The Company’s platforms include: VY-UC to generate immune-privileged universal cells without altering the components that control self-recognitio...
Vycellix, Inc. is a private, immuno-centric discovery life science company, advancing the development of transformational platform technologies to enhance and optimize next-generation cell & gene-based therapies, including T cell and Natural Killer (NK) cell-based cancer therapies. The Company’s platforms include: VY-UC to generate immune-privileged universal cells without altering the components that control self-recognition (HLA), obviating the need for immune-suppressive drugs in contexts of allogeneic cell therapies, hence redefining “off-the-shelf” treatment strategies, VY-OZ to significantly enhance gene transduction rates etc.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4105 E. Fowler Ave. Tampa, FL 33617
Telephone
Telephone
(772) 418-6302
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20251203373099/en/Vycellix-Prepares-for-First-in-Human-Study-of-Novel-Allogeneic-Cell-Therapy-Powered-by-Its-Universal-Cell-Engineering-Platform

BUSINESSWIRE
03 Dec 2025

https://www.businesswire.com/news/home/20230605005545/en

BUSINESSWIRE
05 Jun 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty